Why Nvidia, Google and Microsoft are betting billions on biotech’s AI future
As language models like ChatGPT and Gemini have ushered in a new age of AI in Silicon Valley, powerful tech companies are looking to drug discovery and digital biology.
As language models like ChatGPT and Gemini have ushered in a new age of AI in Silicon Valley, powerful tech companies are looking to drug discovery and digital biology.
The tech giant also announced a slew of Gemini services, including Gemini Advanced, the company’s most powerful AI product, available via its Google One subscription bundle.
The search giant faced a slew of historic cases this year, including a landmark antitrust trial against the federal government, a bitter fight against the maker of Fortnite, and its first-ever gender discrimination trial.
White it is primarily voice activated, it has a tiny projector to beam out laser icons and text on a user’s palm.
In opening statements of the landmark antitrust trial, the U.S. government claimed Google used its dominance to push out rivals, while Google argued its search engine is just the superior product.
With Bard, its newly launched “experimental conversational AI service,” Google’s scrambling to ship AI products. But past scandals, botched launches and a talent drain have put it in a surprise position: playing catch-up in a field it helped create.
The service will be initially available to a limited group of testers before a wider release in “coming weeks.”